- Home
- IMAB vs AMRN Comparison
IMAB vs AMRN Comparison
Compare IMAB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- AMRN
- Stock Information
- Founded
- IMAB 2014
- AMRN 1989
- Country
- IMAB United States
- AMRN Ireland
- Employees
- IMAB N/A
- AMRN N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- IMAB Health Care
- AMRN Health Care
- Exchange
- IMAB Nasdaq
- AMRN Nasdaq
- Market Cap
- IMAB 200.9M
- AMRN 216.0M
- IPO Year
- IMAB 2020
- AMRN 1993
- Fundamental
- Price
- IMAB $2.29
- AMRN $16.65
- Analyst Decision
- IMAB Strong Buy
- AMRN Strong Sell
- Analyst Count
- IMAB 2
- AMRN 1
- Target Price
- IMAB $6.00
- AMRN $12.00
- AVG Volume (30 Days)
- IMAB 1.0M
- AMRN 184.9K
- Earning Date
- IMAB 05-15-2025
- AMRN 07-30-2025
- Dividend Yield
- IMAB N/A
- AMRN N/A
- EPS Growth
- IMAB N/A
- AMRN N/A
- EPS
- IMAB N/A
- AMRN N/A
- Revenue
- IMAB N/A
- AMRN $214,112,000.00
- Revenue This Year
- IMAB N/A
- AMRN N/A
- Revenue Next Year
- IMAB N/A
- AMRN $7.88
- P/E Ratio
- IMAB N/A
- AMRN N/A
- Revenue Growth
- IMAB N/A
- AMRN N/A
- 52 Week Low
- IMAB $0.60
- AMRN $7.08
- 52 Week High
- IMAB $3.08
- AMRN $17.18
- Technical
- Relative Strength Index (RSI)
- IMAB 53.66
- AMRN 74.13
- Support Level
- IMAB $2.00
- AMRN $15.78
- Resistance Level
- IMAB $2.95
- AMRN $17.18
- Average True Range (ATR)
- IMAB 0.35
- AMRN 1.02
- MACD
- IMAB -0.07
- AMRN 0.25
- Stochastic Oscillator
- IMAB 30.53
- AMRN 89.14
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.